Article
Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response
2021-03-10
Abstract excerpt
<h4>ABSTRACT</h4> The rapid spread of COVID-19 underscores the need for new treatments. Here we report that cannabidiol (CBD), a compound produced by the cannabis plant, inhibits SARS-CoV-2 infection. CBD and its metabolite, 7-OH-CBD, but not congeneric cannabinoids, potently block SARS-CoV-2 replication in lung epithelial cells. CBD acts after cellular infection, inhibiting viral gene expression and reversing ma...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 767cd12e-a3f2-5370-909e-a1408958c812
- DOI
- 10.1101/2021.03.10.432967
